ECOG-ACRIN E4412

Primary Category:

Treatment Protocols

Disease Category:

Hodgkin Lymphoma, Lymphoma

Status:

New, Open

A Phase I Study with an Expansion Cohort/Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma

NCT#01896999

Open to Phase II accrual.